Cargando…
Dusp6 Inhibits Epithelial-mesenchymal Transition in Endometrial Adenocarcinoma Via ERK Signaling Pathway
BACKGROUND: Endometrial adenocarcinoma (EAC) is one of the most commonly diagnosed gynaecological malignancies among female population of the developed countries. DUSP6 is a negative regulator of ERK signaling, which is a molecular switch involved in MAPK signaling during the progress of malignancie...
Autores principales: | Fan, Ming-Jun, Liang, Shu-Mei, He, Peng-Juan, Zhao, Xing-Bo, Li, Ming-Jiang, Geng, Feng |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Sciendo
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6765161/ https://www.ncbi.nlm.nih.gov/pubmed/31553703 http://dx.doi.org/10.2478/raon-2019-0034 |
Ejemplares similares
-
Dual-specificity phosphatase (DUSP6) in human glioblastoma: epithelial-to-mesenchymal transition (EMT) involvement
por: Zuchegna, Candida, et al.
Publicado: (2020) -
DUSP5 and DUSP6 modulate corneal epithelial cell proliferation
por: Wang, Zheng, et al.
Publicado: (2010) -
DUSP4 promotes doxorubicin resistance in gastric cancer through epithelial-mesenchymal transition
por: Kang, Xing, et al.
Publicado: (2017) -
The SKA3-DUSP2 Axis Promotes Gastric Cancer Tumorigenesis and Epithelial-Mesenchymal Transition by Activating the MAPK/ERK Pathway
por: Zhang, Chao, et al.
Publicado: (2022) -
Progesterone Inhibits Epithelial-to-Mesenchymal Transition in Endometrial Cancer
por: van der Horst, Paul H., et al.
Publicado: (2012)